Impaired Pulmonary Function in Patients with Psoriasis

dc.contributor.authorBaki, Didem Didar
dc.contributor.authorCelik, Ebru
dc.contributor.authorGenc, Sebahat
dc.contributor.authorCelik, Muhammet Murat
dc.contributor.authorInan, Mehmet Ugur
dc.date.accessioned2024-09-18T20:55:32Z
dc.date.available2024-09-18T20:55:32Z
dc.date.issued2016
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground: Psoriasis is associated with chronic obstructive pulmonary disease. There is no study on the spirometric pulmonary function testing in patients with psoriasis. Objective: The aim of this study was to compare the spirometric parameters in patients with psoriasis and controls. Methods: Ninety-six patients with psoriasis and 60 sex- and age-matched control subjects were included in this study. Spirometric pulmonary function testing, including percent forced vital capacity (FVC%), percent forced expiratory volume in the 1st second (FEV1%), forced expiratory flow at 25-75% of FVC (FEF25-75%), and FEV1/FVC ratio, was performed in all study subjects. Results: The mean FEV1/FVC ratio and FEF25-75% were significantly lower in the psoriasis patients than in the controls (82.4 +/- 6.3 vs. 90.7 +/- 10.7, p < 0.001, and 86.7 +/- 24.2 vs. 94.8 +/- 23.0, p = 0.04, respectively). Both FEV1/FVC ratio and FEF25-75% were significantly associated with the presence of psoriasis (p < 0.001 and p = 0.029, respectively). Conclusion: Psoriasis patients had lower mean FEV1/FVC ratios and FEF25-75%, compared with the control subjects. FEV1/FVC and FEF25-75% are independently associated with the presence of psoriasis. (C) 2017 S. Karger AG, Baselen_US
dc.identifier.doi10.1159/000456032
dc.identifier.endpage667en_US
dc.identifier.issn1018-8665
dc.identifier.issn1421-9832
dc.identifier.issue6en_US
dc.identifier.pmid28226320en_US
dc.identifier.scopus2-s2.0-85013639276en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage664en_US
dc.identifier.urihttps://doi.org/10.1159/000456032
dc.identifier.urihttps://hdl.handle.net/20.500.12483/11897
dc.identifier.volume232en_US
dc.identifier.wosWOS:000400358400005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofDermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPsoriasisen_US
dc.subjectChronic obstructive pulmonary diseaseen_US
dc.subjectSpirometryen_US
dc.subjectPulmonary functionen_US
dc.titleImpaired Pulmonary Function in Patients with Psoriasisen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
106.26 KB
Biçim:
Adobe Portable Document Format